Paper36856421
Novel Transmission-Blocking Antimalarials Identified by High-Throughput Screening of Plasmodium berghei Ookluc.
Calit J and 10 others. Antimicrob Agents Chemother, 2023. Cited by 10 papers, by iCite.
Cite this record
ConductScience Library. Novel Transmission-Blocking Antimalarials Identified by High-Throughput Screening of Plasmodium berghei Ookluc. Papers, record 36856421. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36856421
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antimalarials | Major topic |
| Malaria | Major topic |
| Malaria, Vivax | Major topic |
| Culicidae | Major topic |
| Malaria, Falciparum | Major topic |
| Animals | |
| Humans | |
| Plasmodium berghei | |
| High-Throughput Screening Assays | |
| Primaquine | |
| Plasmodium falciparum |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| ZIAAI001020 | NIH |
Source NIH RePORTER
References45
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26085270 | A novel multiple-stage antimalarial agent that inhibits protein synthesis. | Nature | 2015 | https://conductscience.org/library/papers/26085270 | PubMed |
| 2 | 34570647 | Pyronaridine-Artesunate (Pyramax) for Treatment of Artemisinin- and Piperaquine-Resistant Plasmodium falciparum in the Central Highlands of Vietnam. | Antimicrob Agents Chemother | 2021 | https://conductscience.org/library/papers/34570647 | PubMed |
| 3 | 22990806 | Assessing transmission blockade in Plasmodium spp. | Methods Mol Biol | 2013 | https://conductscience.org/library/papers/22990806 | PubMed |
| 4 | 28513586 | Hundreds of dual-stage antimalarial molecules discovered by a functional gametocyte screen. | Nat Commun | 2017 | https://conductscience.org/library/papers/28513586 | PubMed |
| 5 | 18579783 | In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen. | Proc Natl Acad Sci U S A | 2008 | https://conductscience.org/library/papers/18579783 | PubMed |
| 6 | 15105139 | Novel, rapid, and inexpensive cell-based quantification of antimalarial drug efficacy. | Antimicrob Agents Chemother | 2004 | https://conductscience.org/library/papers/15105139 | PubMed |
| 7 | 25385096 | Pharmacokinetic interactions between primaquine and pyronaridine-artesunate in healthy adult Thai subjects. | Antimicrob Agents Chemother | 2015 | https://conductscience.org/library/papers/25385096 | PubMed |
| 8 | 35544095 | Single low-dose tafenoquine combined with dihydroartemisinin-piperaquine to reduce Plasmodium falciparum transmission in Ouelessebougou, Mali: a phase 2, single-blind, randomised clinical trial. | Lancet Microbe | 2022 | https://conductscience.org/library/papers/35544095 | PubMed |
| 9 | 26749441 | High-Throughput Assay and Discovery of Small Molecules that Interrupt Malaria Transmission. | Cell Host Microbe | 2016 | https://conductscience.org/library/papers/26749441 | PubMed |
| 10 | 22877082 | Review of pyronaridine anti-malarial properties and product characteristics. | Malar J | 2012 | https://conductscience.org/library/papers/22877082 | PubMed |
| 11 | 26666916 | Population Pharmacokinetics of Pyronaridine in Pediatric Malaria Patients. | Antimicrob Agents Chemother | 2015 | https://conductscience.org/library/papers/26666916 | PubMed |
| 12 | 10838414 | A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays. | J Biomol Screen | 1999 | https://conductscience.org/library/papers/10838414 | PubMed |
| 13 | 23742293 | Designing the next generation of medicines for malaria control and eradication. | Malar J | 2013 | https://conductscience.org/library/papers/23742293 | PubMed |
| 14 | 31515284 | A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. | Mol Pharmacol | 2019 | https://conductscience.org/library/papers/31515284 | PubMed |
| 15 | 33219324 | Human Aurora kinase inhibitor Hesperadin reveals epistatic interaction between Plasmodium falciparum PfArk1 and PfNek1 kinases. | Commun Biol | 2020 | https://conductscience.org/library/papers/33219324 | PubMed |
| 16 | 31446060 | High-throughput screening identifies candidate drugs for the treatment of recurrent respiratory papillomatosis. | Papillomavirus Res | 2019 | https://conductscience.org/library/papers/31446060 | PubMed |
| 17 | 14625535 | The cellular geography of aurora kinases. | Nat Rev Mol Cell Biol | 2003 | https://conductscience.org/library/papers/14625535 | PubMed |
| 18 | 33073193 | Torin 2 Derivative, NCATS-SM3710, Has Potent Multistage Antimalarial Activity through Inhibition of P. falciparum Phosphatidylinositol 4-Kinase (Pf PI4KIIIβ). | ACS Pharmacol Transl Sci | 2020 | https://conductscience.org/library/papers/33073193 | PubMed |
| 19 | 26177200 | Novel Phenotypic Outcomes Identified for a Public Collection of Approved Drugs from a Publicly Accessible Panel of Assays. | PLoS One | 2015 | https://conductscience.org/library/papers/26177200 | PubMed |
| 20 | 30814727 | Exposing Anopheles mosquitoes to antimalarials blocks Plasmodium parasite transmission. | Nature | 2019 | https://conductscience.org/library/papers/30814727 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42680902 | New thinking for the next generation of antimalarials. | EMBO Mol Med | 2026 | https://conductscience.org/library/papers/42680902 | PubMed |
| 42391120 | Anti-malarial contact dependent blocking of transmission of Plasmodium vivax by Anopheles darlingi mosquito vector. | PLoS Pathog | 2026 | https://conductscience.org/library/papers/42391120 | PubMed |
| 40364975 | From Colonization to High Production and Plasmodium vivax Infection of Anopheles darlingi and Anopheles deaneorum: a Platform for Malaria Research. | Bio Protoc | 2025 | https://conductscience.org/library/papers/40364975 | PubMed |
| 40266770 | Blood Source and Anesthetics Effects on the Maintenance of Anopheles darlingi in the Lab-Rearing Condition. | Insects | 2025 | https://conductscience.org/library/papers/40266770 | PubMed |
| 39737083 | Two Gracilioethers Containing a [2(5H)-Furanylidene]ethanoate Moiety and 9,10-Dihydroplakortone G: New Polyketides from the Caribbean Marine Sponge Plakortis halichondrioides. | Appl Sci (Basel) | 2024 | https://conductscience.org/library/papers/39737083 | PubMed |
| 39483245 | Pyrimidine Azepine Targets the Plasmodium bc 1 Complex and Displays Multistage Antimalarial Activity. | JACS Au | 2024 | https://conductscience.org/library/papers/39483245 | PubMed |
| 39065810 | Transmission-Blocking Strategies for Malaria Eradication: Recent Advances in Small-Molecule Drug Development. | Pharmaceuticals (Basel) | 2024 | https://conductscience.org/library/papers/39065810 | PubMed |
| 38929667 | Probing the Antiplasmodial Properties of Plakortinic Acids C and D: An Uncommon Pair of Marine Peroxide-Polyketides Isolated from a Two-Sponge Association of Plakortis symbiotica and Xetospongia deweerdtae Collected near Puerto Rico. | Life (Basel) | 2024 | https://conductscience.org/library/papers/38929667 | PubMed |
| 37875508 | Optimization of Plasmodium vivax infection of colonized Amazonian Anopheles darlingi. | Sci Rep | 2023 | https://conductscience.org/library/papers/37875508 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36856421
GET https://conductscience.org/api/papers/v1/36856421/references?page=2